Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials.
Sci Transl Med. 2019 Sep 11;11(509):eaaw8412. doi: 10.1126/scitranslmed.aaw8412.
Sci Transl Med. 2019.
PMID: 31511426
Free PMC article.